lifestyle.jardal-paintball.com

Author: Rakovina Therapeutics Inc

Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update

April 30, 2026
Rakovina Therapeutics Presents New Preclinical Data at AACR 2026 Annual Meeting

April 22, 2026
Rakovina Therapeutics to Present New Data at the AACR Annual Meeting 2026 – World’s Premier Cancer Research Forum

March 23, 2026
Rakovina Therapeutics Announces Extension of Non-Brokered Private Placement

March 12, 2026
Rakovina Announces Closing of $1 Million Debenture Unit Private Placement and Debt Settlement Agreements

March 5, 2026
Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million

February 20, 2026
Rakovina Therapeutics Reports Strong Industry Validation and Emerging Collaborations Following 9th Annual DDR Inhibitors Summit

February 4, 2026
Rakovina Therapeutics Announces Corporate Update Including up to $1.5 Million in New Financing, Leadership Appointments and Debt Restructuring

January 27, 2026